Kevin Bacon
- The role of MKK3 in allergic and non-allergic inflammatory responses in the lungBy Tatjana Holand, Yanira Riffo-Vasquez, Domenico Spina, Brian O'Connor, Francis Woisin, Mike Marber, Kevin Bacon and Christian RolffTatjana Holand1Sackler Institute of Pulmonary Pharmacology, King's College London, London, United KingdomYanira Riffo-Vasquez1Sackler Institute of Pulmonary Pharmacology, King's College London, London, United KingdomDomenico Spina1Sackler Institute of Pulmonary Pharmacology, King's College London, London, United KingdomBrian O'Connor1Sackler Institute of Pulmonary Pharmacology, King's College London, London, United KingdomFrancis Woisin1Sackler Institute of Pulmonary Pharmacology, King's College London, London, United KingdomMike Marber2Cardiovascular Research Division, King's College London, London, United KingdomKevin Bacon
- MKK3 is expressed in cells from patients with allergic asthmaBy Tatjana Holand, Yanira Riffo-Vasquez, Domenico Spina, Brian O'Connor, Francis Woisin, Mike Barber, Kevin Bacon, Christian Rohlff and Clive PageTatjana Holand1Sackler Institute of Pulmonary Pharmacology, King's College London, London, United KingdomYanira Riffo-Vasquez1Sackler Institute of Pulmonary Pharmacology, King's College London, London, United KingdomDomenico Spina1Sackler Institute of Pulmonary Pharmacology, King's College London, London, United KingdomBrian O'Connor1Sackler Institute of Pulmonary Pharmacology, King's College London, London, United KingdomFrancis Woisin1Sackler Institute of Pulmonary Pharmacology, King's College London, London, United KingdomMike Barber2Cardiovascular Research Division, King's College London, London, United KingdomKevin BaconChristian RohlffClive Page1Sackler Institute of Pulmonary Pharmacology, King's College London, London, United Kingdom
- RC kinase: A novel kinase expressed by alveolar macrophages that may play a role in COPD and IPFBy Stefen Boehme, John Ludka, Danielle DiTirro, Ana Lucia Coelho, Cory Hogaboam, Tai Wei Ly and Kevin BaconStefen Boehme1Department of Biology, Axikin Pharmaceuticals, Inc., San Diego, CA, United StatesJohn Ludka1Department of Biology, Axikin Pharmaceuticals, Inc., San Diego, CA, United StatesDanielle DiTirro1Department of Biology, Axikin Pharmaceuticals, Inc., San Diego, CA, United StatesAna Lucia Coelho2Department of Pathology, University of Michigan, Ann Arbor, MI, United StatesCory Hogaboam2Department of Pathology, University of Michigan, Ann Arbor, MI, United StatesTai Wei Ly1Department of Biology, Axikin Pharmaceuticals, Inc., San Diego, CA, United StatesKevin Bacon1Department of Biology, Axikin Pharmaceuticals, Inc., San Diego, CA, United States
- Effect of CCR3 inhibitors on allergic airway responses in ascaris-sensitized cynomolgus monkeysBy Edward Barrett, Karin Rudolph, Chris Royer, T. Ly, S. Boehme and Kevin BaconEdward Barrett1Respiratory Immunology, Lovelace Respiratory Research Institute, Albuquerque, United StatesKarin Rudolph1Respiratory Immunology, Lovelace Respiratory Research Institute, Albuquerque, United StatesChris Royer1Respiratory Immunology, Lovelace Respiratory Research Institute, Albuquerque, United StatesT. Ly2Pharmacology, Axikin Pharmaceuticals, San Diego, United StatesS. Boehme2Pharmacology, Axikin Pharmaceuticals, San Diego, United StatesKevin Bacon2Pharmacology, Axikin Pharmaceuticals, San Diego, United States
- Late-breaking abstract: Inhibition of RC kinase is a novel therapeutic approach for the treatment of COPD and IPFBy Stefen Boehme, Ana Coelho, Cory Hogaboam, Tai Wei Ly, Kevin Bacon and Jon AthanacioStefen Boehme1Biology, Axikin Pharmaceuticals, San Diego, CA,Ana Coelho2Pulmonary and Critical Care Medicine, Cedars Sinai Medical Center, Los Angeles, CA,Cory Hogaboam2Pulmonary and Critical Care Medicine, Cedars Sinai Medical Center, Los Angeles, CA,Tai Wei Ly1Biology, Axikin Pharmaceuticals, San Diego, CA,Kevin Bacon1Biology, Axikin Pharmaceuticals, San Diego, CA,Jon Athanacio1Biology, Axikin Pharmaceuticals, San Diego, CA,
- LATE-BREAKING ABSTRACT: A novel role for CCR3 in promoting airways hyperreactivity; Role for CCR3-muscarinic M3 receptor heterodimersBy Kevin Bacon, Emma Moss, Karen Bingham, Louis-Philippe Boulet, Mark Fitzgerald, Gail Gauvreau, Paul O'Byrne, Taylor Gilliland, Tracy Handel, Tai-Wei Ly and Stefen BoehmeKevin Bacon1Biology, Axikin Pharmaceuticals, Inc, San Diego, CA United StatesEmma Moss2Biology, Biopta Ltd., Glasgow, United KingdomKaren Bingham2Biology, Biopta Ltd., Glasgow, United KingdomLouis-Philippe Boulet3IUCPQ, Institut de Cardiologie et de Pneumologie de l'Hôpital Laval, IUCPQ, Institut de Cardiologie et de Pneumologie de l'Hopital Laval, Quebec, CanadaMark Fitzgerald4UBC Respiratory Division, University of British Columbia, Vancouver, CanadaGail Gauvreau5Department of Medicine, McMaster University, Hsmilton, CanadaPaul O'Byrne5Department of Medicine, McMaster University, Hsmilton, CanadaTaylor Gilliland6Dept of Pharmacology, School of Medicine, University of California, San Diego, San Diego, United StatesTracy Handel6Dept of Pharmacology, School of Medicine, University of California, San Diego, San Diego, United StatesTai-Wei Ly1Biology, Axikin Pharmaceuticals, Inc, San Diego, CA United StatesStefen Boehme1Biology, Axikin Pharmaceuticals, Inc, San Diego, CA United States
- LATE-BREAKING ABSTRACT: Inhibition of MAP3K19 - A novel therapeutic approach for treatment of IPFBy Stefen Boehme, Tai Wei Ly and Kevin BaconStefen BoehmeBiology, Axikin Pharmaceuticals, San Diego, CA United StatesTai Wei LyBiology, Axikin Pharmaceuticals, San Diego, CA United StatesKevin BaconBiology, Axikin Pharmaceuticals, San Diego, CA United States
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.